Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment

J Li, L Zhu, HF Kwok - Drug Resistance Updates, 2023 - Elsevier
Lung cancer continues to be a malignant tumor with high mortality. Two obstacles interfere
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies

F Yang, Q He, X Dai, X Zhang, D Song - Frontiers in pharmacology, 2023 - frontiersin.org
Breast cancer (BC) is the most frequently diagnosed malignant tumor among women in the
world. BC is the heterogeneous tumor with different subtypes including luminal A-like …

Biomimetic camouflaged metal organic framework for enhanced siRNA delivery in tumor environment

T Tao, S ur Rehman, S Xu, J Zhang, H **a… - Journal of Materials …, 2024 - pubs.rsc.org
Gene silencing through RNA interference (RNAi), particularly using small double-stranded
RNA (siRNA), has been identified as a potent strategy for targeted cancer treatment. Yet, its …

Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer

D Sanjanwala, V Patravale - Drug Discovery Today, 2023 - Elsevier
Highlights•Active targeting uses ligands to target drugs to particular tissues or
cells.•Antibodies are commonly used targeting ligands which are bulky and difficult to …

[HTML][HTML] Nanotheranostics: platforms, current applications, and mechanisms of targeting in breast and prostate cancers

PA Akpa, IE Peter, AM Onwuka, BC Obi… - Journal of …, 2023 - mdpi.com
Globally, cancer is one of the deadliest diseases, needing a meticulous diagnosis and
targeted treatment plan to achieve an initial prognosis, followed by precision and …

Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer

M Zhu, X Yang, J You, L Zheng, C Yi… - MedComm …, 2023 - Wiley Online Library
Breast cancer has become the most common and greatest threat to women's health in the
world. As the most dangerous subtype of breast cancer, triple‐negative breast cancer …

Green synthesized AgNPs using Clitoria ternatea extract and its confinement on SBA-15/GPTMS-TAEA for controlled drug release of ciprofloxacin

B Shree Haripriya, DR Anakha, R Yamuna… - Journal of Porous …, 2024 - Springer
Abstract Ag nanoparticles (Ag NPs) were synthesized using Clitoria ternatea plant extract
and confined onto mesoporous SBA-15, functionalized with 3-glycidoxypropyl …

Albumin-based nanosystem for dual-modality imaging-guided chem-phototherapy against immune-cold triple-negative breast cancer

C Peng, X Zeng, J Cai, H Huang, F Yang… - Regenerative …, 2023 - academic.oup.com
Triple-negative breast cancer is a highly aggressive and metastatic tumor; diagnosing it in
the early stages is still difficult, and the prognosis for conventional radio-chemotherapy and …

An Updated Review on the Nanocarriers Based Co‐Delivery System of Chemo Drug Doxorubicin and Phytocompounds

P Pandey, M Verma, S Lakhanpal… - Polymers for …, 2025 - Wiley Online Library
Numerous issues and concerns are associated with current cancer therapeutics, such as
multidrug resistance tumors, drug toxicity, severe side effects, and financial burden …

[HTML][HTML] Identification of transcription factors associated with the disease-free survival of triple-negative breast cancer through weighted gene co-expression network …

H Wang, R Hao, W Liu, Y Zhang, S Ma, Y Lu… - …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: Triple-negative breast cancer (TNBC) is a subtype of breast cancer that has a
worse prognosis than the other subtypes of breast cancer because of its high recurrence …